
A screening for breast cancer (Stock image)
(Picture: PA Archive)Scientists have hailed a “landmark moment” in the treatment of advanced breast cancer after a new drug was shown to slow the growth of the disease.
Capivasertib was found to double the amount of time people have the disease before it progresses in a clinical trial, potentially benefitting up to 8,000 women every year.